ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Coagulation Factor Concentrates Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-19V9511
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Coagulation Factor Concentrates Market Insights and Forecast to 2028
BUY CHAPTERS

Global Coagulation Factor Concentrates Market Research Report 2025

Code: QYRE-Auto-19V9511
Report
September 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
CSL (Australia)
Grifols (Spain)
Shire (Ireland)
Octapharma (Switzerland)
Kedrion (Italy)
Bio Product Laboratory (UK)
Sanquin (Netherlands)
LFB (France)
Biotest (Germany)
Japan Blood Products Organization, China Biologic Products (China)
Green Cross Corporation (South Korea)
Shanghai RAAS Blood Products (China)

Coagulation Factor Concentrates Market Size

The global market for Coagulation Factor Concentrates was valued at US$ 7276 million in the year 2024 and is projected to reach a revised size of US$ 10910 million by 2031, growing at a CAGR of 6.0% during the forecast period.

Coagulation Factor Concentrates Market

Coagulation Factor Concentrates Market

North American market for Coagulation Factor Concentrates is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Coagulation Factor Concentrates is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Coagulation Factor Concentrates include CSL (Australia), Grifols (Spain), Shire (Ireland), Octapharma (Switzerland), Kedrion (Italy), Bio Product Laboratory (UK), Sanquin (Netherlands), LFB (France), Biotest (Germany), Japan Blood Products Organization, China Biologic Products (China), etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Coagulation Factor Concentrates, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Coagulation Factor Concentrates.
The Coagulation Factor Concentrates market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Coagulation Factor Concentrates market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Coagulation Factor Concentrates manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Coagulation Factor Concentrates Market Report

Report Metric Details
Report Name Coagulation Factor Concentrates Market
Accounted market size in year US$ 7276 million
Forecasted market size in 2031 US$ 10910 million
CAGR 6.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Neurology
  • Immunology
  • Hematology
  • Critical Care
  • Pulmonology
  • Hemato-Oncology
  • Rheumatology
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company CSL (Australia), Grifols (Spain), Shire (Ireland), Octapharma (Switzerland), Kedrion (Italy), Bio Product Laboratory (UK), Sanquin (Netherlands), LFB (France), Biotest (Germany), Japan Blood Products Organization, China Biologic Products (China), Green Cross Corporation (South Korea), Shanghai RAAS Blood Products (China)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Coagulation Factor Concentrates manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Coagulation Factor Concentrates in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Coagulation Factor Concentrates Market growing?

Ans: The Coagulation Factor Concentrates Market witnessing a CAGR of 6.0% during the forecast period 2025-2031.

What is the Coagulation Factor Concentrates Market size in 2031?

Ans: The Coagulation Factor Concentrates Market size in 2031 will be US$ 10910 million.

Who are the main players in the Coagulation Factor Concentrates Market report?

Ans: The main players in the Coagulation Factor Concentrates Market are CSL (Australia), Grifols (Spain), Shire (Ireland), Octapharma (Switzerland), Kedrion (Italy), Bio Product Laboratory (UK), Sanquin (Netherlands), LFB (France), Biotest (Germany), Japan Blood Products Organization, China Biologic Products (China), Green Cross Corporation (South Korea), Shanghai RAAS Blood Products (China)

What are the Application segmentation covered in the Coagulation Factor Concentrates Market report?

Ans: The Applications covered in the Coagulation Factor Concentrates Market report are Neurology, Immunology, Hematology, Critical Care, Pulmonology, Hemato-Oncology, Rheumatology, Others

What are the Type segmentation covered in the Coagulation Factor Concentrates Market report?

Ans: The Types covered in the Coagulation Factor Concentrates Market report are Factor VIII, Factor IX, Von Willebrand Factor, Prothrombin Complex Concentrates, Fibrinogen Concentrates, Factor XIII

Recommended Reports

Coagulation Analyzers

Coagulation Factors

Blood Disease Treatment

1 Coagulation Factor Concentrates Market Overview
1.1 Product Definition
1.2 Coagulation Factor Concentrates by Type
1.2.1 Global Coagulation Factor Concentrates Market Value Comparison by Type (2024 VS 2031)
1.2.2 Factor VIII
1.2.3 Factor IX
1.2.4 Von Willebrand Factor
1.2.5 Prothrombin Complex Concentrates
1.2.6 Fibrinogen Concentrates
1.2.7 Factor XIII
1.3 Coagulation Factor Concentrates by Application
1.3.1 Global Coagulation Factor Concentrates Market Value by Application (2024 VS 2031)
1.3.2 Neurology
1.3.3 Immunology
1.3.4 Hematology
1.3.5 Critical Care
1.3.6 Pulmonology
1.3.7 Hemato-Oncology
1.3.8 Rheumatology
1.3.9 Others
1.4 Global Coagulation Factor Concentrates Market Size Estimates and Forecasts
1.4.1 Global Coagulation Factor Concentrates Revenue 2020-2031
1.4.2 Global Coagulation Factor Concentrates Sales 2020-2031
1.4.3 Global Coagulation Factor Concentrates Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Coagulation Factor Concentrates Market Competition by Manufacturers
2.1 Global Coagulation Factor Concentrates Sales Market Share by Manufacturers (2020-2025)
2.2 Global Coagulation Factor Concentrates Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Coagulation Factor Concentrates Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Coagulation Factor Concentrates, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Coagulation Factor Concentrates, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Coagulation Factor Concentrates, Product Type & Application
2.7 Global Key Manufacturers of Coagulation Factor Concentrates, Date of Enter into This Industry
2.8 Global Coagulation Factor Concentrates Market Competitive Situation and Trends
2.8.1 Global Coagulation Factor Concentrates Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Coagulation Factor Concentrates Players Market Share by Revenue
2.8.3 Global Coagulation Factor Concentrates Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Coagulation Factor Concentrates Market Scenario by Region
3.1 Global Coagulation Factor Concentrates Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Coagulation Factor Concentrates Sales by Region: 2020-2031
3.2.1 Global Coagulation Factor Concentrates Sales by Region: 2020-2025
3.2.2 Global Coagulation Factor Concentrates Sales by Region: 2026-2031
3.3 Global Coagulation Factor Concentrates Revenue by Region: 2020-2031
3.3.1 Global Coagulation Factor Concentrates Revenue by Region: 2020-2025
3.3.2 Global Coagulation Factor Concentrates Revenue by Region: 2026-2031
3.4 North America Coagulation Factor Concentrates Market Facts & Figures by Country
3.4.1 North America Coagulation Factor Concentrates Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Coagulation Factor Concentrates Sales by Country (2020-2031)
3.4.3 North America Coagulation Factor Concentrates Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Coagulation Factor Concentrates Market Facts & Figures by Country
3.5.1 Europe Coagulation Factor Concentrates Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Coagulation Factor Concentrates Sales by Country (2020-2031)
3.5.3 Europe Coagulation Factor Concentrates Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Coagulation Factor Concentrates Market Facts & Figures by Region
3.6.1 Asia Pacific Coagulation Factor Concentrates Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Coagulation Factor Concentrates Sales by Region (2020-2031)
3.6.3 Asia Pacific Coagulation Factor Concentrates Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Coagulation Factor Concentrates Market Facts & Figures by Country
3.7.1 Latin America Coagulation Factor Concentrates Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Coagulation Factor Concentrates Sales by Country (2020-2031)
3.7.3 Latin America Coagulation Factor Concentrates Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Coagulation Factor Concentrates Market Facts & Figures by Country
3.8.1 Middle East and Africa Coagulation Factor Concentrates Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Coagulation Factor Concentrates Sales by Country (2020-2031)
3.8.3 Middle East and Africa Coagulation Factor Concentrates Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Coagulation Factor Concentrates Sales by Type (2020-2031)
4.1.1 Global Coagulation Factor Concentrates Sales by Type (2020-2025)
4.1.2 Global Coagulation Factor Concentrates Sales by Type (2026-2031)
4.1.3 Global Coagulation Factor Concentrates Sales Market Share by Type (2020-2031)
4.2 Global Coagulation Factor Concentrates Revenue by Type (2020-2031)
4.2.1 Global Coagulation Factor Concentrates Revenue by Type (2020-2025)
4.2.2 Global Coagulation Factor Concentrates Revenue by Type (2026-2031)
4.2.3 Global Coagulation Factor Concentrates Revenue Market Share by Type (2020-2031)
4.3 Global Coagulation Factor Concentrates Price by Type (2020-2031)
5 Segment by Application
5.1 Global Coagulation Factor Concentrates Sales by Application (2020-2031)
5.1.1 Global Coagulation Factor Concentrates Sales by Application (2020-2025)
5.1.2 Global Coagulation Factor Concentrates Sales by Application (2026-2031)
5.1.3 Global Coagulation Factor Concentrates Sales Market Share by Application (2020-2031)
5.2 Global Coagulation Factor Concentrates Revenue by Application (2020-2031)
5.2.1 Global Coagulation Factor Concentrates Revenue by Application (2020-2025)
5.2.2 Global Coagulation Factor Concentrates Revenue by Application (2026-2031)
5.2.3 Global Coagulation Factor Concentrates Revenue Market Share by Application (2020-2031)
5.3 Global Coagulation Factor Concentrates Price by Application (2020-2031)
6 Key Companies Profiled
6.1 CSL (Australia)
6.1.1 CSL (Australia) Company Information
6.1.2 CSL (Australia) Description and Business Overview
6.1.3 CSL (Australia) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2020-2025)
6.1.4 CSL (Australia) Coagulation Factor Concentrates Product Portfolio
6.1.5 CSL (Australia) Recent Developments/Updates
6.2 Grifols (Spain)
6.2.1 Grifols (Spain) Company Information
6.2.2 Grifols (Spain) Description and Business Overview
6.2.3 Grifols (Spain) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Grifols (Spain) Coagulation Factor Concentrates Product Portfolio
6.2.5 Grifols (Spain) Recent Developments/Updates
6.3 Shire (Ireland)
6.3.1 Shire (Ireland) Company Information
6.3.2 Shire (Ireland) Description and Business Overview
6.3.3 Shire (Ireland) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Shire (Ireland) Coagulation Factor Concentrates Product Portfolio
6.3.5 Shire (Ireland) Recent Developments/Updates
6.4 Octapharma (Switzerland)
6.4.1 Octapharma (Switzerland) Company Information
6.4.2 Octapharma (Switzerland) Description and Business Overview
6.4.3 Octapharma (Switzerland) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Octapharma (Switzerland) Coagulation Factor Concentrates Product Portfolio
6.4.5 Octapharma (Switzerland) Recent Developments/Updates
6.5 Kedrion (Italy)
6.5.1 Kedrion (Italy) Company Information
6.5.2 Kedrion (Italy) Description and Business Overview
6.5.3 Kedrion (Italy) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Kedrion (Italy) Coagulation Factor Concentrates Product Portfolio
6.5.5 Kedrion (Italy) Recent Developments/Updates
6.6 Bio Product Laboratory (UK)
6.6.1 Bio Product Laboratory (UK) Company Information
6.6.2 Bio Product Laboratory (UK) Description and Business Overview
6.6.3 Bio Product Laboratory (UK) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Bio Product Laboratory (UK) Coagulation Factor Concentrates Product Portfolio
6.6.5 Bio Product Laboratory (UK) Recent Developments/Updates
6.7 Sanquin (Netherlands)
6.7.1 Sanquin (Netherlands) Company Information
6.7.2 Sanquin (Netherlands) Description and Business Overview
6.7.3 Sanquin (Netherlands) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Sanquin (Netherlands) Coagulation Factor Concentrates Product Portfolio
6.7.5 Sanquin (Netherlands) Recent Developments/Updates
6.8 LFB (France)
6.8.1 LFB (France) Company Information
6.8.2 LFB (France) Description and Business Overview
6.8.3 LFB (France) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2020-2025)
6.8.4 LFB (France) Coagulation Factor Concentrates Product Portfolio
6.8.5 LFB (France) Recent Developments/Updates
6.9 Biotest (Germany)
6.9.1 Biotest (Germany) Company Information
6.9.2 Biotest (Germany) Description and Business Overview
6.9.3 Biotest (Germany) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Biotest (Germany) Coagulation Factor Concentrates Product Portfolio
6.9.5 Biotest (Germany) Recent Developments/Updates
6.10 Japan Blood Products Organization, China Biologic Products (China)
6.10.1 Japan Blood Products Organization, China Biologic Products (China) Company Information
6.10.2 Japan Blood Products Organization, China Biologic Products (China) Description and Business Overview
6.10.3 Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Product Portfolio
6.10.5 Japan Blood Products Organization, China Biologic Products (China) Recent Developments/Updates
6.11 Green Cross Corporation (South Korea)
6.11.1 Green Cross Corporation (South Korea) Company Information
6.11.2 Green Cross Corporation (South Korea) Description and Business Overview
6.11.3 Green Cross Corporation (South Korea) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Green Cross Corporation (South Korea) Coagulation Factor Concentrates Product Portfolio
6.11.5 Green Cross Corporation (South Korea) Recent Developments/Updates
6.12 Shanghai RAAS Blood Products (China)
6.12.1 Shanghai RAAS Blood Products (China) Company Information
6.12.2 Shanghai RAAS Blood Products (China) Description and Business Overview
6.12.3 Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Product Portfolio
6.12.5 Shanghai RAAS Blood Products (China) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Coagulation Factor Concentrates Industry Chain Analysis
7.2 Coagulation Factor Concentrates Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Coagulation Factor Concentrates Production Mode & Process Analysis
7.4 Coagulation Factor Concentrates Sales and Marketing
7.4.1 Coagulation Factor Concentrates Sales Channels
7.4.2 Coagulation Factor Concentrates Distributors
7.5 Coagulation Factor Concentrates Customer Analysis
8 Coagulation Factor Concentrates Market Dynamics
8.1 Coagulation Factor Concentrates Industry Trends
8.2 Coagulation Factor Concentrates Market Drivers
8.3 Coagulation Factor Concentrates Market Challenges
8.4 Coagulation Factor Concentrates Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
CSL (Australia)
Grifols (Spain)
Shire (Ireland)
Octapharma (Switzerland)
Kedrion (Italy)
Bio Product Laboratory (UK)
Sanquin (Netherlands)
LFB (France)
Biotest (Germany)
Japan Blood Products Organization, China Biologic Products (China)
Green Cross Corporation (South Korea)
Shanghai RAAS Blood Products (China)
List of Tables
 Table 1. Global Coagulation Factor Concentrates Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Coagulation Factor Concentrates Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Coagulation Factor Concentrates Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Coagulation Factor Concentrates Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Coagulation Factor Concentrates Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Coagulation Factor Concentrates Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Coagulation Factor Concentrates Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Coagulation Factor Concentrates Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Coagulation Factor Concentrates, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Coagulation Factor Concentrates, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Coagulation Factor Concentrates, Product Type & Application
 Table 12. Global Key Manufacturers of Coagulation Factor Concentrates, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Coagulation Factor Concentrates by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coagulation Factor Concentrates as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Coagulation Factor Concentrates Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Coagulation Factor Concentrates Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Coagulation Factor Concentrates Sales Market Share by Region (2020-2025)
 Table 19. Global Coagulation Factor Concentrates Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Coagulation Factor Concentrates Sales Market Share by Region (2026-2031)
 Table 21. Global Coagulation Factor Concentrates Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Coagulation Factor Concentrates Revenue Market Share by Region (2020-2025)
 Table 23. Global Coagulation Factor Concentrates Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Coagulation Factor Concentrates Revenue Market Share by Region (2026-2031)
 Table 25. North America Coagulation Factor Concentrates Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Coagulation Factor Concentrates Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Coagulation Factor Concentrates Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Coagulation Factor Concentrates Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Coagulation Factor Concentrates Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Coagulation Factor Concentrates Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Coagulation Factor Concentrates Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Coagulation Factor Concentrates Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Coagulation Factor Concentrates Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Coagulation Factor Concentrates Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Coagulation Factor Concentrates Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Coagulation Factor Concentrates Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Coagulation Factor Concentrates Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Coagulation Factor Concentrates Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Coagulation Factor Concentrates Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Coagulation Factor Concentrates Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Coagulation Factor Concentrates Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Coagulation Factor Concentrates Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Coagulation Factor Concentrates Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Coagulation Factor Concentrates Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Coagulation Factor Concentrates Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Coagulation Factor Concentrates Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Coagulation Factor Concentrates Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Coagulation Factor Concentrates Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Coagulation Factor Concentrates Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Coagulation Factor Concentrates Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Coagulation Factor Concentrates Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Coagulation Factor Concentrates Sales Market Share by Type (2020-2025)
 Table 53. Global Coagulation Factor Concentrates Sales Market Share by Type (2026-2031)
 Table 54. Global Coagulation Factor Concentrates Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Coagulation Factor Concentrates Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Coagulation Factor Concentrates Revenue Market Share by Type (2020-2025)
 Table 57. Global Coagulation Factor Concentrates Revenue Market Share by Type (2026-2031)
 Table 58. Global Coagulation Factor Concentrates Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Coagulation Factor Concentrates Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Coagulation Factor Concentrates Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Coagulation Factor Concentrates Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Coagulation Factor Concentrates Sales Market Share by Application (2020-2025)
 Table 63. Global Coagulation Factor Concentrates Sales Market Share by Application (2026-2031)
 Table 64. Global Coagulation Factor Concentrates Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Coagulation Factor Concentrates Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Coagulation Factor Concentrates Revenue Market Share by Application (2020-2025)
 Table 67. Global Coagulation Factor Concentrates Revenue Market Share by Application (2026-2031)
 Table 68. Global Coagulation Factor Concentrates Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Coagulation Factor Concentrates Price (USD/Pcs) by Application (2026-2031)
 Table 70. CSL (Australia) Company Information
 Table 71. CSL (Australia) Description and Business Overview
 Table 72. CSL (Australia) Coagulation Factor Concentrates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. CSL (Australia) Coagulation Factor Concentrates Product
 Table 74. CSL (Australia) Recent Developments/Updates
 Table 75. Grifols (Spain) Company Information
 Table 76. Grifols (Spain) Description and Business Overview
 Table 77. Grifols (Spain) Coagulation Factor Concentrates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Grifols (Spain) Coagulation Factor Concentrates Product
 Table 79. Grifols (Spain) Recent Developments/Updates
 Table 80. Shire (Ireland) Company Information
 Table 81. Shire (Ireland) Description and Business Overview
 Table 82. Shire (Ireland) Coagulation Factor Concentrates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Shire (Ireland) Coagulation Factor Concentrates Product
 Table 84. Shire (Ireland) Recent Developments/Updates
 Table 85. Octapharma (Switzerland) Company Information
 Table 86. Octapharma (Switzerland) Description and Business Overview
 Table 87. Octapharma (Switzerland) Coagulation Factor Concentrates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Octapharma (Switzerland) Coagulation Factor Concentrates Product
 Table 89. Octapharma (Switzerland) Recent Developments/Updates
 Table 90. Kedrion (Italy) Company Information
 Table 91. Kedrion (Italy) Description and Business Overview
 Table 92. Kedrion (Italy) Coagulation Factor Concentrates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Kedrion (Italy) Coagulation Factor Concentrates Product
 Table 94. Kedrion (Italy) Recent Developments/Updates
 Table 95. Bio Product Laboratory (UK) Company Information
 Table 96. Bio Product Laboratory (UK) Description and Business Overview
 Table 97. Bio Product Laboratory (UK) Coagulation Factor Concentrates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Bio Product Laboratory (UK) Coagulation Factor Concentrates Product
 Table 99. Bio Product Laboratory (UK) Recent Developments/Updates
 Table 100. Sanquin (Netherlands) Company Information
 Table 101. Sanquin (Netherlands) Description and Business Overview
 Table 102. Sanquin (Netherlands) Coagulation Factor Concentrates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. Sanquin (Netherlands) Coagulation Factor Concentrates Product
 Table 104. Sanquin (Netherlands) Recent Developments/Updates
 Table 105. LFB (France) Company Information
 Table 106. LFB (France) Description and Business Overview
 Table 107. LFB (France) Coagulation Factor Concentrates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. LFB (France) Coagulation Factor Concentrates Product
 Table 109. LFB (France) Recent Developments/Updates
 Table 110. Biotest (Germany) Company Information
 Table 111. Biotest (Germany) Description and Business Overview
 Table 112. Biotest (Germany) Coagulation Factor Concentrates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. Biotest (Germany) Coagulation Factor Concentrates Product
 Table 114. Biotest (Germany) Recent Developments/Updates
 Table 115. Japan Blood Products Organization, China Biologic Products (China) Company Information
 Table 116. Japan Blood Products Organization, China Biologic Products (China) Description and Business Overview
 Table 117. Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 118. Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Product
 Table 119. Japan Blood Products Organization, China Biologic Products (China) Recent Developments/Updates
 Table 120. Green Cross Corporation (South Korea) Company Information
 Table 121. Green Cross Corporation (South Korea) Description and Business Overview
 Table 122. Green Cross Corporation (South Korea) Coagulation Factor Concentrates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 123. Green Cross Corporation (South Korea) Coagulation Factor Concentrates Product
 Table 124. Green Cross Corporation (South Korea) Recent Developments/Updates
 Table 125. Shanghai RAAS Blood Products (China) Company Information
 Table 126. Shanghai RAAS Blood Products (China) Description and Business Overview
 Table 127. Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 128. Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Product
 Table 129. Shanghai RAAS Blood Products (China) Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Coagulation Factor Concentrates Distributors List
 Table 133. Coagulation Factor Concentrates Customers List
 Table 134. Coagulation Factor Concentrates Market Trends
 Table 135. Coagulation Factor Concentrates Market Drivers
 Table 136. Coagulation Factor Concentrates Market Challenges
 Table 137. Coagulation Factor Concentrates Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Coagulation Factor Concentrates
 Figure 2. Global Coagulation Factor Concentrates Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Coagulation Factor Concentrates Market Share by Type: 2024 & 2031
 Figure 4. Factor VIII Product Picture
 Figure 5. Factor IX Product Picture
 Figure 6. Von Willebrand Factor Product Picture
 Figure 7. Prothrombin Complex Concentrates Product Picture
 Figure 8. Fibrinogen Concentrates Product Picture
 Figure 9. Factor XIII Product Picture
 Figure 10. Global Coagulation Factor Concentrates Market Value by Application (2020-2031) & (US$ Million)
 Figure 11. Global Coagulation Factor Concentrates Market Share by Application: 2024 & 2031
 Figure 12. Neurology
 Figure 13. Immunology
 Figure 14. Hematology
 Figure 15. Critical Care
 Figure 16. Pulmonology
 Figure 17. Hemato-Oncology
 Figure 18. Rheumatology
 Figure 19. Others
 Figure 20. Global Coagulation Factor Concentrates Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 21. Global Coagulation Factor Concentrates Market Size (2020-2031) & (US$ Million)
 Figure 22. Global Coagulation Factor Concentrates Sales (2020-2031) & (K Pcs)
 Figure 23. Global Coagulation Factor Concentrates Average Price (USD/Pcs) & (2020-2031)
 Figure 24. Coagulation Factor Concentrates Report Years Considered
 Figure 25. Coagulation Factor Concentrates Sales Share by Manufacturers in 2024
 Figure 26. Global Coagulation Factor Concentrates Revenue Share by Manufacturers in 2024
 Figure 27. Global 5 and 10 Largest Coagulation Factor Concentrates Players: Market Share by Revenue in Coagulation Factor Concentrates in 2024
 Figure 28. Coagulation Factor Concentrates Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 29. Global Coagulation Factor Concentrates Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 30. North America Coagulation Factor Concentrates Sales Market Share by Country (2020-2031)
 Figure 31. North America Coagulation Factor Concentrates Revenue Market Share by Country (2020-2031)
 Figure 32. U.S. Coagulation Factor Concentrates Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Canada Coagulation Factor Concentrates Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Europe Coagulation Factor Concentrates Sales Market Share by Country (2020-2031)
 Figure 35. Europe Coagulation Factor Concentrates Revenue Market Share by Country (2020-2031)
 Figure 36. Germany Coagulation Factor Concentrates Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. France Coagulation Factor Concentrates Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. U.K. Coagulation Factor Concentrates Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Italy Coagulation Factor Concentrates Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Russia Coagulation Factor Concentrates Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Asia Pacific Coagulation Factor Concentrates Sales Market Share by Region (2020-2031)
 Figure 42. Asia Pacific Coagulation Factor Concentrates Revenue Market Share by Region (2020-2031)
 Figure 43. China Coagulation Factor Concentrates Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Japan Coagulation Factor Concentrates Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. South Korea Coagulation Factor Concentrates Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. India Coagulation Factor Concentrates Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Australia Coagulation Factor Concentrates Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Taiwan Coagulation Factor Concentrates Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Indonesia Coagulation Factor Concentrates Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Thailand Coagulation Factor Concentrates Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Malaysia Coagulation Factor Concentrates Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Philippines Coagulation Factor Concentrates Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Latin America Coagulation Factor Concentrates Sales Market Share by Country (2020-2031)
 Figure 54. Latin America Coagulation Factor Concentrates Revenue Market Share by Country (2020-2031)
 Figure 55. Mexico Coagulation Factor Concentrates Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Brazil Coagulation Factor Concentrates Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Argentina Coagulation Factor Concentrates Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Middle East and Africa Coagulation Factor Concentrates Sales Market Share by Country (2020-2031)
 Figure 59. Middle East and Africa Coagulation Factor Concentrates Revenue Market Share by Country (2020-2031)
 Figure 60. Turkey Coagulation Factor Concentrates Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 61. Saudi Arabia Coagulation Factor Concentrates Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 62. UAE Coagulation Factor Concentrates Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 63. Global Sales Market Share of Coagulation Factor Concentrates by Type (2020-2031)
 Figure 64. Global Revenue Market Share of Coagulation Factor Concentrates by Type (2020-2031)
 Figure 65. Global Coagulation Factor Concentrates Price (USD/Pcs) by Type (2020-2031)
 Figure 66. Global Sales Market Share of Coagulation Factor Concentrates by Application (2020-2031)
 Figure 67. Global Revenue Market Share of Coagulation Factor Concentrates by Application (2020-2031)
 Figure 68. Global Coagulation Factor Concentrates Price (USD/Pcs) by Application (2020-2031)
 Figure 69. Coagulation Factor Concentrates Value Chain
 Figure 70. Channels of Distribution (Direct Vs Distribution)
 Figure 71. Bottom-up and Top-down Approaches for This Report
 Figure 72. Data Triangulation
 Figure 73. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Coagulation Reagent Market Research Report 2025
Global Coagulation Factor Concentrate Market Research Report 2025
Global Coagulants Market Research Report 2024
Human Fibrinogen Concentrate Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Blood Coagulation Factor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Food Coagulators Market Research Report 2025
Global Clotting Factors Ⅷ Market Insights Forecast to 2030
Global Suction Coagulators Market Research Report 2025
Global Recombinant Coagulation Factor Concentrate Market Research Report 2024
Global Flocculants and Coagulants for Water Treatment Market Research Report 2025
Global Concrete Coagulant Market Research Report 2025
Global Coagulation Detector Market Research Report 2024
Global Fully Auto Coagulation Analyzer Market Research Report 2025
Clotting Factor Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Coagulation Vats Market Research Report 2025
Global Human Coagulation Factor IV Market Research Report 2024
Global Milk Coagulants Market Research Report 2024
Global Water Treatment Coagulant Market Research Report 2025
Global Recombinant Factor Products Market Research Report 2024
Global Organic Coagulant Market Insights Forecast to 2030

RELATED REPORTS

Global Cephalosporin APIs and Cephalosporin Intermediates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19G16926
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global ELISA Immunoassay Plates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7Z17064
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Ready-to-Use ELISA Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20P20045
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Moxidectin Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3Z19977
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions